MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to common...
-$11,837K
Other income
(expense), net
$19K
Interest income, net
$1,390K
Foreign currency
transaction gain (loss)
$131K
Net loss
-$11,837K
Total other income,
net
$1,540K
Loss from operations
-$13,377K
Total operating
expenses
$13,377K
General and
administrative
$7,543K
Research and development
$5,834K
Back
Back
Income Statement
source: myfinsight.com
Benitec Biopharma Inc. (BNTC)
Benitec Biopharma Inc. (BNTC)